Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence. Biomedical Research and Therapy, [S. l.], v. 8, n. 9, p. 4583–4595, 2021. DOI: 10.15419/bmrat.v8i9.694. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/694.. Acesso em: 15 nov. 2024.